PP
BMY icon

PagnatoKarp Partners’s Bristol-Myers Squibb BMY Stock Holding History

PagnatoKarp Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,095
Closed -$841K – 21
2020
Q1 		$841K Sell
15,095
-411
-3% -$25.1K 0.21% 63
2019
Q4 		$995K Buy
15,506
+811
+6% +$46.4K 0.17% 67
2019
Q3 		$745K Buy
14,695
+38
+0.3% +$1.79K 0.15% 74
2019
Q2 		$665K Buy
14,657
+99
+0.7% +$4.61K 0.14% 77
2019
Q1 		$695K Buy
14,558
+1
+0% +$50 0.16% 74
2018
Q4 		$757K Sell
14,557
-87
-0.6% -$4.67K 0.16% 68
2018
Q3 		$909K Buy
14,644
+112
+0.8% +$6.65K 0.27% 55
2018
Q2 		$804K Buy
14,532
+440
+3% +$23.8K 0.26% 58
2018
Q1 		$891K Sell
14,092
-1,637
-10% -$105K 0.38% 48
2017
Q4 		$964K Sell
15,729
-240
-2% -$15K 0.28% 55
2017
Q3 		$1.02M Buy
15,969
+173
+1% +$10.1K 0.26% 50
2017
Q2 		$880K Sell
15,796
-118
-0.7% -$6.42K 0.27% 53
2017
Q1 		$865K Buy
15,914
+285
+2% +$15.6K 0.25% 49
2016
Q4 		$914K Buy
+15,629
New +$854K 0.27% 49

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PagnatoKarp Partners's BMY Position: Q2 2020 in Review

PagnatoKarp Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 15,095 shares — an estimated $841K sold.

PagnatoKarp Partners first reported a position in BMY in Q4 2016 and held it in 14 quarters. The position peaked at $1.02M in Q3 2017. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • PagnatoKarp Partners reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • PagnatoKarp Partners sold 15,095 Bristol-Myers Squibb shares in Q2 2020, an estimated $841K.
  • PagnatoKarp Partners first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 14 quarters.
  • PagnatoKarp Partners's Bristol-Myers Squibb position peaked at $1.02M in Q3 2017.
  • 2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on PagnatoKarp Partners's 13F filing for Q2 2020.